Antipsychotic-like effects of a neurotensin receptor type 1 agonistChelsea A. Vadnie, Doo‐Sup Choi, Sun Choi et al.|Behavioural Brain Research|2016Cited by 25
Activation of neurotensin receptor type 1 decreases hyperlocomotion and glycogen synthase kinase-3 activityChelsea A. Vadnie, Doo‐Sup Choi, Jennifer Ayers-Ringler et al.|Journal of the Neurological Sciences|2015Cited by 0